????? ?? ?? ? ??? ????????????? ????????????????? ??????????????????? 103,104 Each trials concluded that early therapy in asymptomatic clients wasn't affiliated with a prolonged All round survival. Quite recently, preliminary benefits from a third trial comparing ibrutinib compared to NetE